PTO- 2300 |
Approved for use through 11/30/2020. OMB 0651-0051 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Input Field | Entered |
---|---|
SERIAL NUMBER | 88296767 |
LAW OFFICE ASSIGNED | LAW OFFICE 121 |
MARK SECTION | |
MARK | CTX130 (standard characters, see http://uspto.report/TM/88296767/mark.png) |
OWNER SECTION(current) | |
NAME | CRISPR Therapeutics AG |
MAILING ADDRESS | Aeschenvorstadt 36 |
CITY | Basel |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | Switzerland |
ZIP/POSTAL CODE | 4051 |
XXXX | |
OWNER SECTION(proposed) | |
STATEMENT TEXT |
By submission of this request, the undersigned requests that the following be made of record for the owner/holder: |
NAME | CRISPR Therapeutics AG |
MAILING ADDRESS | Baarerstrasse 14 |
CITY | ZUG V8 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | Switzerland |
ZIP/POSTAL CODE | 6300 |
XXXX | |
CORRESPONDENCE SECTION(current) | |
NAME | Tiffany D. Gehrke |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | docket@marshallip.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | tgehrke@marshallip.com |
DOCKET/REFERENCE NUMBER(S) | 33324/60000 |
CORRESPONDENCE SECTION (proposed) | |
NAME | Tiffany D. Gehrke |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | docket@marshallip.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | tgehrke@marshallip.com |
DOCKET/REFERENCE NUMBER(S) | 33324/60000 |
SIGNATURE SECTION | |
SIGNATURE | /Tiffany D Gehrke/ |
SIGNATORY NAME | Tiffany D. Gehrke |
SIGNATORY DATE | 04/07/2021 |
SIGNATORY POSITION | Attorney of Record, IL Bar Member |
SIGNATORY PHONE NUMBER | 312 474 6300 |
ROLE OF AUTHORIZED SIGNATORY | Authorized U.S.-Licensed Attorney |
SIGNATURE METHOD | Sent to third party for signature |
FILING INFORMATION SECTION | |
SUBMIT DATE | Wed Apr 07 10:40:56 ET 2021 |
TEAS STAMP | USPTO/CAR-XX.XXX.XX.XXX-2 0210407104056897557-88296 767-7706e7b85367c05f16d86 5296ebebe7a7b9fdbb724ab66 e3658dff47f97432ae-N/A-N/ A-20210406152449368237 |
PTO- 2300 |
Approved for use through 11/30/2020. OMB 0651-0051 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |